Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
3
×
boston blog main
life sciences
national blog main
national top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
bio
3
×
ipo
medicines
3
×
covid
new
roundup
acquisitions
activity
analysis
announced
approvals
biogen
biotech
bring
ceo
clamped
collabs
company
daniel
deal
delays
develop
developing
diseases
drug
economic
employing
fast
fda
genetic
gilead
gilead’s
goldfinch
help
including
introduce
isn’t
kidney
later
lead
Language
unset
Current search:
medicines
×
biotech
×
bio
×
photo
×
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More